These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35745773)

  • 1. Cu
    Zhang Y; Lou J; Williams GR; Ye Y; Ren D; Shi A; Wu J; Chen W; Zhu LM
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.
    Vaghasiya K; Ray E; Sharma A; Katare OP; Verma RK
    ACS Appl Bio Mater; 2020 Aug; 3(8):4987-4999. PubMed ID: 35021676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma.
    Zhang P; Cao F; Zhang J; Tan Y; Yao S
    Heliyon; 2023 Aug; 9(8):e18490. PubMed ID: 37576252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Therapeutic Proficiency of Dual-Targeted Mesoporous Silica Nanocomposite Endorses Combination Drug Delivery.
    Murugan C; Venkatesan S; Kannan S
    ACS Omega; 2017 Nov; 2(11):7959-7975. PubMed ID: 30023569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mesoporous silica nanoparticles (MSNs) for highly controllable drug release and synergistic therapy.
    Cheng YJ; Zeng X; Cheng DB; Xu XD; Zhang XZ; Zhuo RX; He F
    Colloids Surf B Biointerfaces; 2016 Sep; 145():217-225. PubMed ID: 27182657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
    Bhavsar DB; Patel V; Sawant KK
    Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A redox-responsive mesoporous silica nanoparticle with a therapeutic peptide shell for tumor targeting synergistic therapy.
    Xiao D; Hu JJ; Zhu JY; Wang SB; Zhuo RX; Zhang XZ
    Nanoscale; 2016 Sep; 8(37):16702-16709. PubMed ID: 27714082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.
    Li ZY; Liu Y; Wang XQ; Liu LH; Hu JJ; Luo GF; Chen WH; Rong L; Zhang XZ
    ACS Appl Mater Interfaces; 2013 Aug; 5(16):7995-8001. PubMed ID: 23869943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Sensitive Drug Delivery System Based on Mesoporous Silica Modified with Poly-L-Lysine (PLL) as a Gatekeeper.
    Lee NK; Park SS; Ha CS
    J Nanosci Nanotechnol; 2020 Nov; 20(11):6925-6934. PubMed ID: 32604538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
    Lin CH; Cheng SH; Liao WN; Wei PR; Sung PJ; Weng CF; Lee CH
    Int J Pharm; 2012 Jun; 429(1-2):138-47. PubMed ID: 22465413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.